Newcrest have reported late last year on this, and there were some very reasonable intersections, obviously enough to them to commit to further exploration
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025